Koyfin Home > Directory > Health Care > Akebia Therapeutics > Total Debt / (EBITDA-CAPEX)

Akebia Therapeutics Total Debt / (EBITDA-CAPEX) Chart (AKBA)

Akebia Therapeutics annual/quarterly Total Debt / (EBITDA-CAPEX) from 2014 to 2020.
  • Akebia Therapeutics Total Debt / (EBITDA-CAPEX) for the quarter ending June 06, 2020 was $-1m a 78.38% decrease of -1m year over year
  • Akebia Therapeutics Total Debt / (EBITDA-CAPEX) for the last 12 months ending June 06, 2020 was $-1m a 72.43% decrease of -1m year over year
  • Akebia Therapeutics Annual Total Debt / (EBITDA-CAPEX) for 2019 was $-1m a 84.24% decrease of -1m from 2018
  • Akebia Therapeutics Annual Total Debt / (EBITDA-CAPEX) for 2018 was $0m
Other Ratios Metrics:
  • Akebia Therapeutics Total Debt / Capital for the quarter ending December 12, 2018 was $2m a 99.29% increase of 2m year over year
  • Akebia Therapeutics Other Liabilities for the quarter ending December 12, 2018 was $95m a 0.76% increase of 1m year over year
  • Akebia Therapeutics Total Debt / Equity for the quarter ending December 12, 2018 was $2m a 99.31% increase of 2m year over year
View Chart On Koyfin

Quarterly AKBA Total Debt / (EBITDA-CAPEX) Data

06/2020$-1m
03/2020$-1m
12/2019$0m
09/2019$0m
06/2019$0m
03/2019$0m
12/2018$0m
09/2017$0m
06/2017$0m
03/2017$0m

Annual AKBA Total Debt / (EBITDA-CAPEX) Data

2019$-1m
2018$0m